Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kannel, W. B.
Right arrow Articles by McGee, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kannel, W. B.
Right arrow Articles by McGee, D. L.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 2, Issue 2 120-126, Copyright © 1979 by American Diabetes Association

ARTICLES

Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study

WB Kannel and DL McGee

This report examines prospectively, in the Framingham cohort, the relation of diabetes and impaired glucose tolerance to each of the cardiovascular sequelae, taking into account age, sex, and associated cardiovascular risk factors. The incidence of cardiovascular disease, as well as the levels of cardiovascular risk factors, were found to be higher in diabetic than in nondiabetic men and women. The relative impact of diabetes on coronary heart disease, peripheral vascular disease, or stroke incidence was the same in men and women, but for cardiovascular mortality and cardiac failure the impact is greater for women. Present evidence suggests that alleviation of associated cardiovascular risk factors is the most promising course in reducing cardiovascular sequelae in diabetic patients.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 CirculationHome page
S. Kenchaiah, H. D. Sesso, and J. M. Gaziano
Body Mass Index and Vigorous Physical Activity and the Risk of Heart Failure Among Men
Circulation, January 6, 2009; 119(1): 44 - 52.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
B. J. Wells, A. Jain, S. Arrigain, C. Yu, W. A. Rosenkrans Jr., and M. W. Kattan
Predicting 6-Year Mortality Risk in Patients With Type 2 Diabetes
Diabetes Care, December 1, 2008; 31(12): 2301 - 2306.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
H. Ogawa, M. Nakayama, T. Morimoto, S. Uemura, M. Kanauchi, N. Doi, H. Jinnouchi, S. Sugiyama, Y. Saito, and for the Japanese Primary Prevention of Atheroscler
Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes: A Randomized Controlled Trial
JAMA, November 12, 2008; 300(18): 2134 - 2141.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
U Bulugahapitiya, S Siyambalapitiya, J Sithole, D J Fernando, and I Idris
Age threshold for vascular prophylaxis by aspirin in patients without diabetes
Heart, November 1, 2008; 94(11): 1429 - 1432.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
B T Srinivasan, J Jarvis, K Khunti, and M J Davies
Recent advances in the management of type 2 diabetes mellitus: a review
Postgrad. Med. J., October 1, 2008; 84(996): 524 - 531.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
A. C. Dale, L. J Vatten, T. I. Nilsen, K. Midthjell, and R. Wiseth
Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: cohort study
BMJ, August 13, 2008; 337(jul01_2): a236 - a236.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
V. A. Fonseca, J. Rosenstock, A. C. Wang, K. E. Truitt, and M. R. Jones
Colesevelam HCl Improves Glycemic Control and Reduces LDL Cholesterol in Patients With Inadequately Controlled Type 2 Diabetes on Sulfonylurea-Based Therapy
Diabetes Care, August 1, 2008; 31(8): 1479 - 1484.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. J. Nicholls, E. M. Tuzcu, S. Kalidindi, K. Wolski, K.-W. Moon, I. Sipahi, P. Schoenhagen, and S. E. Nissen
Effect of Diabetes on Progression of Coronary Atherosclerosis and Arterial Remodeling: A Pooled Analysis of 5 Intravascular Ultrasound Trials
J. Am. Coll. Cardiol., July 22, 2008; 52(4): 255 - 262.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
E. A. Molenaar, S.-J. Hwang, R. S. Vasan, D. E. Grobbee, J. B. Meigs, R. B. D'Agostino Sr., D. Levy, and C. S. Fox
Burden and Rates of Treatment and Control of Cardiovascular Disease Risk Factors in Obesity: The Framingham Heart Study
Diabetes Care, July 1, 2008; 31(7): 1367 - 1372.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
B. V. Howard, M. J. Roman, R. B. Devereux, J. L. Fleg, J. M. Galloway, J. A. Henderson, Wm. J. Howard, E. T. Lee, M. Mete, B. Poolaw, et al.
Effect of Lower Targets for Blood Pressure and LDL Cholesterol on Atherosclerosis in Diabetes: The SANDS Randomized Trial
JAMA, April 9, 2008; 299(14): 1678 - 1689.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
Y. Takata, H. Osawa, M. Kurata, M. Kurokawa, J. Yamauchi, M. Ochi, W. Nishida, T. Okura, J. Higaki, and H. Makino
Hyperresistinemia Is Associated With Coexistence of Hypertension and Type 2 Diabetes
Hypertension, February 1, 2008; 51(2): 534 - 539.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
A. C. Dale, T. I. Nilsen, L. Vatten, K. Midthjell, and R. Wiseth
Diabetes mellitus and risk of fatal ischaemic heart disease by gender: 18 years follow-up of 74 914 individuals in the HUNT 1 Study
Eur. Heart J., December 1, 2007; 28(23): 2924 - 2929.
[Abstract] [Full Text] [PDF]

Home page
 Clin. DiabetesHome page
W. Schaffner, S. J. Rehm, and T. A. Elasy
Influenza Vaccination: An Unmet Need in Patients With Diabetes
Clin. Diabetes, October 1, 2007; 25(4): 145 - 149.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. Uribarri, A. Stirban, D. Sander, W. Cai, M. Negrean, C. E. Buenting, T. Koschinsky, and H. Vlassara
Single Oral Challenge by Advanced Glycation End Products Acutely Impairs Endothelial Function in Diabetic and Nondiabetic Subjects
Diabetes Care, October 1, 2007; 30(10): 2579 - 2582.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. Siyambalapitiya, U. Bulugahapitiya, J. Sithole, S. Song, D. J.S. Fernando, and I. Idris
Combining Population Health and Baseline Risk Strategy by Determining an Age Cutoff for Initiating Statins in Patients With Diabetes: A population-based study
Diabetes Care, August 1, 2007; 30(8): 2025 - 2029.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
O. H. Franco, E. W. Steyerberg, F. B. Hu, J. Mackenbach, and W. Nusselder
Associations of Diabetes Mellitus With Total Life Expectancy and Life Expectancy With and Without Cardiovascular Disease
Arch Intern Med, June 11, 2007; 167(11): 1145 - 1151.
[Abstract] [Full Text] [PDF]

Home page
 British Journal of Diabetes & Vascular DiseaseHome page
R. E Pratley and G. Matfin
Review: Pre-diabetes: clinical relevance and therapeutic approach
The British Journal of Diabetes & Vascular Disease, May 1, 2007; 7(3): 120 - 129.
[Abstract] [PDF]

Home page
 J Am Coll CardiolHome page
E. Erdmann, J. A. Dormandy, B. Charbonnel, M. Massi-Benedetti, I. K. Moules, A. M. Skene, and on behalf of the PROactive Investigators
The Effect of Pioglitazone on Recurrent Myocardial Infarction in 2,445 Patients With Type 2 Diabetes and Previous Myocardial Infarction: Results From the PROactive (PROactive 05) Study
J. Am. Coll. Cardiol., May 1, 2007; 49(17): 1772 - 1780.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. Miyazaki-Akita, T. Hayashi, Q. F. Ding, H. Shiraishi, T. Nomura, Y. Hattori, and A. Iguchi
17beta-Estradiol Antagonizes the Down-Regulation of Endothelial Nitric-Oxide Synthase and GTP Cyclohydrolase I by High Glucose: Relevance to Postmenopausal Diabetic Cardiovascular Disease
J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 591 - 598.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. L. Rogers, A. R. Mitchell, C. Maric, K. Sandberg, A. Myers, and S. E. Mulroney
Effect of sex hormones on renal estrogen and angiotensin type 1 receptors in female and male rats
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R794 - R799.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
L. Wu, R. Vikramadithyan, S. Yu, C. Pau, Y. Hu, I. J. Goldberg, and H. M. Dansky
Addition of dietary fat to cholesterol in the diets of LDL receptor knockout mice: effects on plasma insulin, lipoproteins, and atherosclerosis
J. Lipid Res., October 1, 2006; 47(10): 2215 - 2222.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
P. H. McNulty
Metabolic responsiveness to insulin in the diabetic heart
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1749 - H1751.
[Full Text] [PDF]

Home page
 DiabetesHome page
K. P. Burdon, J. L. Bento, C. D. Langefeld, J. K. Campbell, J. J. Carr, L. M. Wagenknecht, D. M. Herrington, B. I. Freedman, S. S. Rich, and D. W. Bowden
Association of Protein Tyrosine Phosphatase-N1 Polymorphisms With Coronary Calcified Plaque in the Diabetes Heart Study
Diabetes, March 1, 2006; 55(3): 651 - 658.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
B. V. Howard, L. G. Best, J. M. Galloway, W. J. Howard, K. Jones, E. T. Lee, R. E. Ratner, H. E. Resnick, and R. B. Devereux
Coronary Heart Disease Risk Equivalence in Diabetes Depends on Concomitant Risk Factors
Diabetes Care, February 1, 2006; 29(2): 391 - 397.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. Scognamiglio, C. Negut, A. Ramondo, A. Tiengo, and A. Avogaro
Detection of Coronary Artery Disease in Asymptomatic Patients With Type 2 Diabetes Mellitus
J. Am. Coll. Cardiol., January 3, 2006; 47(1): 65 - 71.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Jawa, S. Nachimuthu, M. Pendergrass, S. Asnani, and V. Fonseca
Impaired Vascular Reactivity in African-American Patients with Type 2 Diabetes Mellitus and Microalbuminuria or Proteinuria Despite Angiotensin-Converting Enzyme Inhibitor Therapy
J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 31 - 35.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. Scognamiglio, C. Negut, A. Ramondo, A. Tiengo, and A. Avogaro
Detection of Coronary Artery Disease in Asymptomatic Patients With Type 2 Diabetes Mellitus
J. Am. Coll. Cardiol., December 13, 2005; (2005) j.jacc.2005.10.008v1.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
P. Raggi, A. Bellasi, and C. Ratti
Ischemia Imaging and Plaque Imaging in Diabetes: Complementary tools to improve cardiovascular risk management
Diabetes Care, November 1, 2005; 28(11): 2787 - 2794.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
P. Muntner, R. P. Wildman, K. Reynolds, K. B. DeSalvo, J. Chen, and V. Fonseca
Relationship Between HbA1c Level and Peripheral Arterial Disease
Diabetes Care, August 1, 2005; 28(8): 1981 - 1987.
[Abstract] [Full Text] [PDF]

Home page
 ANGIOLOGYHome page
D. A. Stakos, D. P. Schuster, E. A. Sparks, C. F. Wooley, K. Osei, and H. Boudoulas
Cardiovascular Effects of Type 1 Diabetes Mellitus in Children
Angiology, May 1, 2005; 56(3): 311 - 317.
[Abstract] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
A. Brea, D. Mosquera, E. Martin, A. Arizti, J. L. Cordero, and E. Ros
Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis: A Case-Control Study
Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 1045 - 1050.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
H. Schuster
Under-treated high-risk patients: identifying patients in high-risk subgroups and treating them to LDL-C targets
Eur. Heart J. Suppl., March 1, 2005; 7(suppl_A): A20 - A28.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
C. S. Fox, S. Coady, P. D. Sorlie, D. Levy, J. B. Meigs, R. B. D'Agostino Sr, P. W. F. Wilson, and P. J. Savage
Trends in Cardiovascular Complications of Diabetes
JAMA, November 24, 2004; 292(20): 2495 - 2499.
[Abstract] [Full Text] [PDF]

Home page
 J Am Board Fam MedHome page
E. A. Meagher
Addressing Cardiovascular Disease in Women: Focus on Dyslipidemia
J Am Board Fam Med, November 1, 2004; 17(6): 424 - 437.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
E. Chiquette, G. Ramirez, and R. DeFronzo
A Meta-analysis Comparing the Effect of Thiazolidinediones on Cardiovascular Risk Factors
Arch Intern Med, October 25, 2004; 164(19): 2097 - 2104.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
Y. Yu, K. Ohmori, Y. Chen, C. Sato, H. Kiyomoto, K. Shinomiya, H. Takeuchi, K. Mizushige, and M. Kohno
Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model
J. Am. Coll. Cardiol., August 18, 2004; 44(4): 904 - 913.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
B. E. Suys, N. Katier, R. P.A. Rooman, D. Matthys, L. Op De Beeck, M. V.L. Du Caju, and D. De Wolf
Female Children and Adolescents With Type 1 Diabetes Have More Pronounced Early Echocardiographic Signs of Diabetic Cardiomyopathy
Diabetes Care, August 1, 2004; 27(8): 1947 - 1953.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
B. V. Howard, J. Hsia, P. Ouyang, L. Van Voorhees, J. Lindsay, A. Silverman, E. L. Alderman, M. Tripputi, and D. D. Waters
Postmenopausal Hormone Therapy Is Associated With Atherosclerosis Progression in Women With Abnormal Glucose Tolerance
Circulation, July 13, 2004; 110(2): 201 - 206.
[Abstract] [Full Text] [PDF]

Home page
 J Clin PharmacolHome page
S. Mudaliar
Intense Management of Diabetes Mellitus: Role of Glucose Control and Antiplatelet Agents
J. Clin. Pharmacol., April 1, 2004; 44(4): 414 - 422.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
C. S. Fox, L. Sullivan, R. B. D'Agostino Sr, and P. W.F. Wilson
The Significant Effect of Diabetes Duration on Coronary Heart Disease Mortality: The Framingham Heart Study
Diabetes Care, March 1, 2004; 27(3): 704 - 708.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. Jesmin, I. Sakuma, Y. Hattori, and A. Kitabatake
Role of Angiotensin II in Altered Expression of Molecules Responsible for Coronary Matrix Remodeling in Insulin-Resistant Diabetic Rats
Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 2021 - 2026.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
Y. Aso, K.-i. Okumura, K. Takebayashi, S. Wakabayashi, and T. Inukai
Relationships of Plasma Interleukin-18 Concentrations to Hyperhomocysteinemia and Carotid Intimal-Media Wall Thickness in Patients With Type 2 Diabetes
Diabetes Care, September 1, 2003; 26(9): 2622 - 2627.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
A. Becker, G. Bos, F. de Vegt, P. J Kostense, J. M Dekker, G. Nijpels, R. J Heine, L. M Bouter, and C. D.A Stehouwer
Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease: 10-year follow-up of the Hoorn Study
Eur. Heart J., August 1, 2003; 24(15): 1406 - 1413.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
G. S. Werner, B. M. Richartz, S. Heinke, M. Ferrari, and H. R. Figulla
Impaired acute collateral recruitment as a possible mechanism for increased cardiac adverse events in patients with diabetes mellitus
Eur. Heart J., June 2, 2003; 24(12): 1134 - 1142.
[Abstract] [Full Text] [PDF]

Home page
 British Journal of Diabetes & Vascular DiseaseHome page
Y. Samarasinghe, M. Al-Mrayat, M. Vloemans, and N. Munro
NICE guidelines for management of lipids in type 2 diabetes mellitus: a practical interpretation
The British Journal of Diabetes & Vascular Disease, May 1, 2003; 3(3): 222 - 225.
[PDF]

Home page
 Diabetes CareHome page
M. W. Massing, K. A. Foley, C. A. Sueta, M. Chowdhury, D. P. Biggs, C. M. Alexander, and R. J. Simpson Jr.
Trends in Lipid Management Among Patients With Coronary Artery Disease: Has diabetes received the attention it deserves?
Diabetes Care, April 1, 2003; 26(4): 991 - 997.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
L. E. Eberly, J. D. Cohen, R. Prineas, and L. Yang
Impact of Incident Diabetes and Incident Nonfatal Cardiovascular Disease on 18-Year Mortality: The Multiple Risk Factor Intervention Trial experience
Diabetes Care, March 1, 2003; 26(3): 848 - 854.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
R. Ferrara, G. Guardigli, and R. Ferrari
Myocardial metabolism: the diabetic heart
Eur. Heart J. Suppl., January 1, 2003; 5(suppl_B): B15 - B18.
[Abstract] [PDF]

Home page
 CirculationHome page
References
Circulation, December 17, 2002; 106(25): 3373 - 3421.
[Full Text]

Home page
 Diabetes CareHome page
M. Tamminen, J. Westerbacka, S. Vehkavaara, and H. Yki-Jarvinen
Insulin-Induced Decreases in Aortic Wave Reflection and Central Systolic Pressure Are Impaired in Type 2 Diabetes
Diabetes Care, December 1, 2002; 25(12): 2314 - 2319.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. N. Friedman, L. G. Hunsicker, J. Selhub, A. G. Bostom, and The Collaborative Study Group
Proteinuria as a Predictor of Total Plasma Homocysteine Levels in Type 2 Diabetic Nephropathy
Diabetes Care, November 1, 2002; 25(11): 2037 - 2041.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
T. Y. Goraya, C. L. Leibson, P. J. Palumbo, S. A. Weston, J. M. Killian, E. A. Pfeifer, S. J. Jacobsen, R. L. Frye, and V.e. L. Roger
Coronary atherosclerosis in diabetes mellitus: A population-based autopsy study
J. Am. Coll. Cardiol., September 4, 2002; 40(5): 946 - 953.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. F.L. Schinkel, A. Elhendy, R. T. van Domburg, J. J. Bax, E. C. Vourvouri, F. B. Sozzi, R. Valkema, J. R.T.C. Roelandt, and D. Poldermans
Prognostic Value of Dobutamine-Atropine Stress Myocardial Perfusion Imaging in Patients With Diabetes
Diabetes Care, September 1, 2002; 25(9): 1637 - 1643.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
S. Kenchaiah, J. C. Evans, D. Levy, P. W.F. Wilson, E. J. Benjamin, M. G. Larson, W. B. Kannel, and R. S. Vasan
Obesity and the Risk of Heart Failure
N. Engl. J. Med., August 1, 2002; 347(5): 305 - 313.
[Abstract] [Full Text] [PDF]

Home page
 Int J EpidemiolHome page
T. F Thomsen, D. McGee, M. Davidsen, and T. Jorgensen
A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study
Int. J. Epidemiol., August 1, 2002; 31(4): 817 - 822.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
E. Bonora, G. Formentini, F. Calcaterra, S. Lombardi, F. Marini, L. Zenari, F. Saggiani, M. Poli, S. Perbellini, A. Raffaelli, et al.
HOMA-Estimated Insulin Resistance Is an Independent Predictor of Cardiovascular Disease in Type 2 Diabetic Subjects: Prospective data from the Verona Diabetes Complications Study
Diabetes Care, July 1, 2002; 25(7): 1135 - 1141.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
P. W. J. C. Serruys, P. de Feyter, C. Macaya, N. Kokott, J. Puel, M. Vrolix, A. Branzi, M. C. Bertolami, G. Jackson, B. Strauss, et al.
Fluvastatin for Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention: A Randomized Controlled Trial
JAMA, June 26, 2002; 287(24): 3215 - 3222.
[Abstract] [Full Text] [PDF]

Home page